Overview
Doripenem in the Treatment of Complicated Lower Urinary Tract Infection or Pyelonephritis
Status:
Completed
Completed
Trial end date:
2006-03-01
2006-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to compare the microbiological cure rate of doripenem versus a comparator antibiotic in the treatment of patients with complicated urinary tract infection or pyelonephritis. The study will also characterize the safety and tolerability of treatment with doripenem in patients with complicated urinary tract infection or pyelonephritis.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Collaborator:
Peninsula Pharmaceuticals, Inc.
Criteria
Inclusion Criteria:- Diagnosis of complicated lower urinary tract infection or pyelonephritis
Exclusion Criteria:
- Women who are pregnant, nursing or of child-bearing potential and not using a
medically accepted, effective method of birth control
- History of moderate or severe hypersensitivity reactions to antibiotic medications